Parotid Tumors Market Research Report Information By Type (Pleomorphic Adenoma), Treatment (Removal Of Lymph Node, Radiation Therapy, Chemotherapy), Diagnosis (Ct Scan, Ultrasound, Sialography) And End Users (Hospitals, Specialty Centers) - Forecast Till 2032

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Parotid Tumors Market, by Type

6.1 Introduction

6.2 Pleomorphic Adenoma

6.2.1 Market Estimates & Forecast, 2023-2030

6.3 Warthin's Tumor

6.3.1 Market Estimates & Forecast, 2023-2030

6.4 Cancerous/Malignant Tumor

6.4.1 Market Estimates & Forecast, 2023-2030

7. Global Parotid Tumors Market, by Diagnosis

7.1 Introduction

7.2 X-Ray

7.2.1 Market Estimates & Forecast, 2023-2030

7.3 CT Scan

7.3.1 Market Estimates & Forecast, 2023-2030

7.4 MRI

7.4.1 Market Estimates & Forecast, 2023-2030

7.5 Ultrasound

7.5.1 Market Estimates & Forecast, 2023-2030

7.6 FNAC (Fine Needle Aspiration Cytology)

7.6.1 Market Estimates & Forecast, 2023-2030

7.7 Sialography

7.7.1 Market Estimates & Forecast, 2023-2030

7.8 Others

7.8.1 Market Estimates & Forecast, 2023-2030

8. Global Parotid Tumors Market, by Treatment

8.1 Introduction

8.2 Parotidectomy

8.2.1 Market Estimates & Forecast, 2023-2030

8.3 Removal of Lymph Node

8.3.1 Market Estimates & Forecast, 2023-2030

8.4 Reconstructive Surgery

8.4.1 Market Estimates & Forecast, 2023-2030

8.5 Radiation Therapy

8.5.1 Market Estimates & Forecast, 2023-2030

8.6.1 Market Estimates & Forecast, 2023-2030

9. Global Parotid Tumors Market, by End User

9.1 Introduction

9.2 Hospitals

9.2.1 Market Estimates & Forecast, 2023-2030

9.3 Specialty centers

9.3.1 Market Estimates & Forecast, 2023-2030

9.4 Research centers

9.4.1 Market Estimates & Forecast, 2023-2030

10 Global Parotid Tumors Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 U.K.

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Eli lilly & Co

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Bayer AG

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Merck & Co. Inc.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Pfizer Inc.

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Bristol-Myers Squibb

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Janssen Global Services, LLC

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Hoffmann-La Roche Ltd

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical Industry

14 Appendix

LIST OF TABLES

Table 1 Parotid Tumors Industry Synopsis, 2023-2030

Table 2 Global Parotid Tumors Market Estimates and Forecast, 2023-2030, (USD Million)

Table 3 Global Parotid Tumors Market by Region, 2023-2030, (USD Million)

Table 5 Global Parotid Tumors Market by Treatment, 2023-2030, (USD Million)

Table 6 Global Parotid Tumors Market by Diagnosis, 2023-2030, (USD Million)

Table 7 Global Parotid Tumors Market by End Users, 2023-2030, (USD Million)

Table 8 North America Parotid Tumors Market by Treatment, 2023-2030, (USD Million)

Table 9 North America Parotid Tumors Market by Daignosis, 2023-2030, (USD Million)

Table 10 North America Parotid Tumors Market by End Users, 2023-2030, (USD Million)

Table 11 US Parotid Tumors Market by Treatment, 2023-2030, (USD Million)

Table 12 US Parotid Tumors Market by Daignosis, 2023-2030, (USD Million)

Table 13 US Parotid Tumors Market by End Users, 2023-2030, (USD Million)

Table 14 Canada Parotid Tumors Market by Treatment, 2023-2030, (USD Million)

Table 15 Canada Parotid Tumors Market by Daignosis, 2023-2030, (USD Million)

Table 16 Canada Parotid Tumors Market by End Users, 2023-2030, (USD Million)

Table 17 South America Parotid Tumors Market by Treatment, 2023-2030, (USD Million)

Table 18 South America Parotid Tumors Market by Diagnosis, 2023-2030, (USD Million)

Table 19 South America Parotid Tumors Market by End Users, 2023-2030, (USD Million)

Table 20 Europe Parotid Tumors Market by Treatment, 2023-2030, (USD Million)

Table 21 Europe Parotid Tumors Market by Diagnosis, 2023-2030, (USD Million)

Table 22 Europe Parotid Tumors Market by End Users, 2023-2030, (USD Million)

Table 23 Western Europe Parotid Tumors Market by Treatment, 2023-2030, (USD Million)

Table 24 Western Europe Parotid Tumors Market by diagnosis, 2023-2030, (USD Million)

Table 25 Western Europe Parotid Tumors Market by End Users, 2023-2030, (USD Million)

Table 26 Eastern Europe Parotid Tumors Market by Treatment, 2023-2030, (USD Million)

Table 27 Eastern Europe Parotid Tumors Market by diagnosis, 2023-2030, (USD Million)

Table 28 Eastern Europe Parotid Tumors Market by End Users, 2023-2030, (USD Million)

Table 29 Asia Pacific Parotid Tumors Market by Treatment, 2023-2030, (USD Million)

Table 30 Asia Pacific Parotid Tumors Market by diagnosis, 2023-2030, (USD Million)

Table 31 Asia Pacific Parotid Tumors Market by End Users, 2023-2030, (USD Million)

Table 32 Middle East & Africa Parotid Tumors Market by Treatment, 2023-2030, (USD Million)

Table 33 Middle East & Africa Parotid Tumors Market by diagnoses, 2023-2030, (USD Million)

Table 34 Middle East & Africa Parotid Tumors Market by End Users, 2023-2030, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Parotid Tumors Market

Figure 3 Segmentation Market Dynamics for Parotid Tumors Market

Figure 4 Global Parotid Tumors Market Share, by Treatment 2023

Figure 5 Global Parotid Tumors Market Share, by Diagnosis 2023

Figure 6 Global Parotid Tumors Market Share, by End Users, 2023

Figure 7 Global Parotid Tumors Market Share, by Region, 2023

Figure 8 North America Parotid Tumors Market Share, by Country, 2023

Figure 9 Europe Parotid Tumors Market Share, by Country, 2023

Figure 10 Asia Pacific Parotid Tumors Market Share, by Country, 2023

Figure 11 Middle East & Africa Parotid Tumors Market Share, by Country, 2023

Figure 12 Global Parotid Tumors Market: Company Share Analysis, 2023 (%)

Figure 13 Bayer AG: Key Financials

Figure 14 Bayer AG: Segmental Revenue

Figure 16 Bayer AG: Geographical Revenue

Figure 17 Pfizer Inc.: Key Financials

Figure 18 Pfizer Inc.: Segmental Revenue

Figure 19 Pfizer Inc.: Geographical Revenue

Figure 20 Hoffmann-La Roche Ltd: Key Financials

Figure 21 Hoffmann-La Roche Ltd: Segmental Revenue

Figure 22 Hoffmann-La Roche Ltd: Geographical Revenue

Figure 23 Novartis AG: Key Financials

Figure 24 Novartis AG: Segmental Revenue

Figure 25 Novartis AG: Geographical Revenue

Figure 26 AstraZeneca: Key Financials

Figure 27 AstraZeneca: Segmental Revenue

Figure 28 AstraZeneca: Geographical Revenue

Figure 29 Amgen: Key Financials

Figure 30 Amgen: Segmental Revenue

Figure 31 Amgen: Geographical Revenue

Figure 32 Johnson & Johnson: Key Financials

Figure 33 Johnson & Johnson: Segmental Revenue

Figure 34 Johnson & Johnson: Geographical Revenue